WallStreetZen

NYSE: NVS
Novartis Ag Stock Forecast, Predictions & Price Target

Analyst price target for NVS

Based on 1 analysts offering 12 month price targets for Novartis Ag.
Min Forecast
$105.00+23.65%
Avg Forecast
$105.00+23.65%
Max Forecast
$105.00+23.65%

Should I buy or sell NVS stock?

Based on 3 analysts offering ratings for Novartis Ag.
Sell
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
2 analysts 66.67%
Sell
0 analysts 0%
Strong Sell
1 analysts 33.33%

NVS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Deutsche Bank
Top 46%
55
Strong SellDowngradesN/AN/A2021-09-20
Argus Research
Top 30%
71
HoldDowngradesN/AN/A2021-03-10
Cowen & Co.
Top 39%
62
HoldDowngrades$105.00+23.65%2021-02-01

1 of 1

Forecast return on equity

Is NVS forecast to generate an efficient return?
Company
31.21%
Industry
75.11%
Market
17.3%
NVS's Return on Equity is forecast to be high in 3 years (31.21%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is NVS forecast to generate an efficient return on assets?
Company
13.6%
Industry
16.47%
NVS is forecast to generate lower Return on Assets (13.6%) than the US Drug Manufacturers - General industry average (16.47%)
Forecast

NVS earnings per share forecast

What is NVS's earnings per share in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$6.28+57.79%
Avg 2 year Forecast
$6.69+68.09%
Avg 3 year Forecast
$7.11+78.64%
NVS's earnings are forecast to grow at an exceptional rate of 21.32% per year
Forecast

NVS revenue forecast

What is NVS's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$52.2B+1.25%
Avg 2 year Forecast
$53.8B+4.33%
Avg 3 year Forecast
$54.9B+6.42%
NVS's revenue is forecast to grow at a rate of 2.15% per year, which is not exceptional
Forecast

NVS earnings growth forecast

How is NVS forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
21.32%
Industry
22.55%
Market
18.31%
NVS's earnings are forecast to grow slower (21.32% per year) than the US Drug Manufacturers - General industry average (22.55%)
Forecast
NVS's earnings are forecast to grow faster (21.32% per year) than the US market average (18.31%)
Forecast
NVS's earnings are forecast to grow faster (21.32% per year) than the risk-free savings rate (1.7%)
Forecast

NVS revenue growth forecast

How is NVS forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
2.15%
Industry
4.71%
Market
11.79%
NVS's revenues are forecast to grow slower (2.15% per year) than the US Drug Manufacturers - General industry average (4.71%)
Forecast
NVS's revenues are forecast to grow slower (2.15% per year) than the US market average (11.79%)
Forecast

Novartis Ag Stock Forecast FAQ

Is Novartis Ag Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NYSE: NVS) stock is to Sell NVS stock.

Out of 3 analysts, 0 (0%) are recommending NVS as a Strong Buy, 0 (0%) are recommending NVS as a Buy, 2 (66.67%) are recommending NVS as a Hold, 0 (0%) are recommending NVS as a Sell, and 1 (33.33%) are recommending NVS as a Strong Sell.

What is NVS's earnings growth forecast for 2021-2023?

(NYSE: NVS) Novartis Ag's forecast annual earnings growth rate of 21.32% is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 22.55%, and while it is forecast to beat the US market's average forecast earnings growth rate of 18.31%.

Novartis Ag's earnings in 2021 is $8,984,000,000.On average, 5 Wall Street analysts forecast NVS's earnings for 2021 to be $14,046,721,152, with the lowest NVS earnings forecast at $13,644,108,126, and the highest NVS earnings forecast at $14,315,129,837. On average, 5 Wall Street analysts forecast NVS's earnings for 2022 to be $14,963,784,158, with the lowest NVS earnings forecast at $14,359,864,618, and the highest NVS earnings forecast at $15,209,825,452.

In 2023, NVS is forecast to generate $15,903,214,553 in earnings, with the lowest earnings forecast at $15,813,744,992 and the highest earnings forecast at $15,992,684,115.

What is NVS's revenue growth forecast for 2021-2023?

(NYSE: NVS) Novartis Ag's forecast annual revenue growth rate of 2.15% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 4.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.79%.

Novartis Ag's revenue in 2021 is $51,556,000,000.On average, 2 Wall Street analysts forecast NVS's revenue for 2021 to be $116,758,090,874,865, with the lowest NVS revenue forecast at $116,009,096,440,935, and the highest NVS revenue forecast at $117,507,085,308,795. On average, 2 Wall Street analysts forecast NVS's revenue for 2022 to be $120,311,631,734,033, with the lowest NVS revenue forecast at $119,383,060,706,517, and the highest NVS revenue forecast at $121,240,202,761,548.

In 2023, NVS is forecast to generate $122,723,227,845,250 in revenue, with the lowest revenue forecast at $120,157,755,271,982 and the highest revenue forecast at $125,288,700,418,518.

What is NVS's forecast return on assets (ROA) for 2021-2024?

(NYSE: NVS) forecast ROA is 13.6%, which is lower than the forecast US Drug Manufacturers - General industry average of 16.47%.

What is NVS's Price Target?

According to 1 Wall Street analysts that have issued a 1 year NVS price target, the average NVS price target is $105.00, with the highest NVS stock price forecast at $105.00 and the lowest NVS stock price forecast at $105.00.

On average, Wall Street analysts predict that Novartis Ag's share price could stay at $105.00 by Sep 20, 2022. The average Novartis Ag stock price prediction forecasts a potential downside of N/A from the current NVS share price of $84.92.

What is NVS's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: NVS) Novartis Ag's current Earnings Per Share (EPS) is $3.98. On average, analysts forecast that NVS's EPS will be $6.28 for 2021, with the lowest EPS forecast at $6.10, and the highest EPS forecast at $6.40. On average, analysts forecast that NVS's EPS will be $6.69 for 2022, with the lowest EPS forecast at $6.42, and the highest EPS forecast at $6.80. In 2023, NVS's EPS is forecast to hit $7.11 (min: $7.07, max: $7.15).

What is NVS's forecast return on equity (ROE) for 2021-2024?

(NYSE: NVS) forecast ROE is 31.21%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.